Investor relations

Zealand maintains an active approach to IR in order to provide transparency into our business and our activities. We strive to ensure the basis for a dynamic and open dialogue with investors, sell-side analysts as well as other external stakeholders.

In line with the disclosure requirements for companies listed on NASDAQ Copenhagen, Zealand issues announcements to inform of relevant news relating the company and its business activities. Further, we issue investor news on a frequent basis and hold conference calls in order to reach investors effectively. We also attend and present at investor conferences in both the US and Europe and travel to the main financial cities frequently to meet with investors.

To receive news releases directly, please register your name and e-mail address on this page. For all shareholders please register your e-mail address via the Shareholder portal.

We encourage investors, analysts and other external stakeholders to contact us with any questions or other enquiries relating to Zealand. Please find our IR Policy here..


Mats Blom

Executive Vice President, Chief Financial Officer
Phone: +45 31 53 79 73
investors@zealandpharma.com